The Role of Medical Management for Acute Intravascular Hemolysis in Patients Supported on Axial Flow LVAD

ASAIO Journal

Volumn 60, Issue 1, 2014, Pages 9-14

  Hasin, Tal ^a   Deo, Salil ^a   Maleszewski, Joseph J ^a   Topilsky, Yan ^a   Edwards, Brooks S ^a   Pereira, Naveen L ^a   Stulak, John M ^a   Joyce, Lyle ^a   Daly, Richard ^a   Kushwaha, Sudhir S ^a   Park, Soon J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Heart assist device; hemolysis; management; outcome; thrombosis

Indexed keywords

HEART ASSIST DEVICE; HEMOLYSIS; LACTATE DEHYDROGENASE; LONG-TERM STRATEGY; MEDICAL MANAGEMENT; OUTCOME; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR (TPA);

BLOOD; LEFT VENTRICULAR ASSIST DEVICES; MANAGEMENT;

PATIENT TREATMENT;

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; LACTATE DEHYDROGENASE; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; FEMALE; FOLLOW UP; HUMAN; INTRAVASCULAR HEMOLYSIS; KIDNEY FAILURE; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RECURRENT DISEASE; SPLEEN INFARCTION; YOUNG ADULT;

ADULT; AGED; ANTICOAGULANTS; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HEMOLYSIS; HUMANS; MALE; MIDDLE AGED; THROMBOSIS; YOUNG ADULT;

EID: 84891873763     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0000000000000012     Document Type: Article

References (29)

1. Rose EA, Gelijns AC, Moskowitz AJ, et al; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group: Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345: 1435-1443, 2001.
2. Slaughter MS, Rogers JG, Milano CA, et al; HeartMate II Investigators: Advanced heart failure treated with contin-uous-fow left ventricular assist device. N Engl J Med 361: 2241-2251, 2009.
3. Kirklin JK, Naftel DC, Kormos RL, et al: Third INTERMACS Annual Report: The evolution of destination therapy in the United States. J Heart Lung Transplant 30: 115-123, 2011.
4. Amir O, Bracey AW, Smart FW, Delgado RM 3rd, Shah N, Kar B: A successful anticoagulation protocol for the frst HeartMate II implantation in the United States. Tex Heart Inst J 32: 399-401, 2005.
5. Crow S, John R, Boyle A, et al: Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg 137: 208-215, 2009.
6. Pagani FD, Miller LW, Russell SD, et al; HeartMate II Investigators: Extended mechanical circulatory support with a continuous-fow rotary left ventricular assist device. J Am Coll Cardiol 54: 312-321, 2009.
7. John R, Kamdar F, Liao K, et al: Low thromboembolic risk for patients with the Heartmate II left ventricular assist device. J Thorac Cardiovasc Surg 136: 1318-1323, 2008.
8. Pereira NL, Chen D, Kushwaha SS, Park SJ: Discontinuation of antithrombotic therapy for a year or more in patients with continuous-fow left ventricular assist devices. Interact Cardiovasc Thorac Surg 11: 503-505, 2010.
9. Bhamidipati CM, Ailawadi G, Bergin J, Kern JA: Early thrombus in a HeartMate II left ventricular assist device: A potential cause of hemolysis and diagnostic dilemma. J Thorac Cardiovasc Surg 140: e7-e8, 2010.
10. Topilsky Y, Hasin T, Oh JK, et al: Echocardiographic variables after left ventricular assist device implantation associated with adverse outcome. Circ Cardiovasc Imaging 4: 648-661, 2011.
11. Uriel N, Morrison KA, Garan AR, et al: Development of a nove echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-fow left ventricular assist devices: The Columbia ramp study. J Am Coll Cardiol 60: 1764-1775, 2012.
12. Kiernan MS, Pham DT, DeNofrio D, Kapur NK: Management of HeartWare left ventricular assist device thrombosis using intracavitary thrombolytics. J Thorac Cardiovasc Surg 142: 712-714, 2011.
13. Rothenburger M, Wilhelm MJ, Hammel D, et al: Treatment of thrombus formation associated with the MicroMed DeBakey VAD using recombinant tissue plasminogen activator. Circulation 106(12 suppl 1): I189-I192, 2002.
14. Delgado R 3rd, Frazier OH, Myers TJ, et al: Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device. J Heart Lung Transplant 24: 231-233, 2005.
15. Hayes H, Dembo L, Larbalestier R, O'Driscoll G: Successful treatment of ventricular assist device associated ventricular thrombus with systemic tenecteplase. Heart Lung Circ 17: 253-255, 2008.
16. Heilmann C, Geisen U, Benk C, et al: Haemolysis in patients with ventricular assist devices: Major differences between systems. Eur J Cardiothorac Surg 36: 580-584, 2009.
17. Boyle AJ, Russell SD, Teuteberg JJ, et al: Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: Analysis of outpatient anti-coagulation. J Heart Lung Transplant 28: 881-887, 2009.
18. Linneweber J, Dohmen PM, Kertzscher U, et al: The effect of surface roughness on activation of the coagulation system and platelet adhesion in rotary blood pumps. Artif Organs 31: 345-351, 2007.
19. Hamilton KF, Schmidt VI, Mager I, Schmitz-Rode T, Steinseifer U: Consequences arising from elevated surface temperatures on human blood. Artif Organs 34: 783-787, 2010.
20. John R, Panch S, Hrabe J, et al: Activation of endothelial and coagulation systems in left ventricular assist device recipients. Ann Thorac Surg 88: 1171-1179, 2009.
21. Slaughter MS, Sobieski MA, Gallagher C, Graham J, Brandise J, Stein R: Fibrinolytic activation during long-term support with the HeartMate II left ventricular assist device. ASAIO J 54: 115-119, 2008.
22. Majeed F, Kop WJ, Poston RS, Kallam S, Mehra MR: Prospective, observational study of antiplatelet and coagulation biomarkers as predictors of thromboembolic events after implantation of ventricular assist devices. Nat Clin Pract Cardiovasc Med 6: 147-157, 2009.
23. Jennings D, McDonnell J, Schillig J: Assessment of long-term anticoagulation in patients with a continuous-fow left-ventricular assist device: A pilot study. J Thorac Cardiovasc Surg 142: e1-e2, 2011.
24. Slaughter MS, Sobieski MA 2nd, Graham JD, Pappas PS, Tatooles AJ, Koenig SC: Platelet activation in heart failure patients supported by the HeartMate II ventricular assist device. Int J Artif Organs 34: 461-468, 2011.
25. Dewald O, Schmitz C, Diem H, et al: Platelet activation markers in patients with heart assist device. Artif Organs 29: 292-299, 2005.
26. Studer MA, Kennedy CE, Dreyer WJ, et al: An alternative treatment strategy for pump thrombus in the DeBakey VAD Child: Use of clopidogrel as a thrombolytic agent. J Heart Lung Transplant 25: 857-861, 2006.
27. Thomas MD, Wood C, Lovett M, Dembo L, O'Driscoll G: Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofban. J Heart Lung Transplant 27: 925-927, 2008.
28. Meyer AL, Kuehn C, Weidemann J, et al: Thrombus formation in a HeartMate II left ventricular assist device. J Thorac Cardiovasc Surg 135: 203-204, 2008.
29. Meola S, Burns G, Sukavaneshvar S, Solen K, Mohammad S: Mitigation of device-associated thrombosis and thromboembo-ism using combinations of heparin and tirofban. J Extra Corpor Technol 38: 230-234, 2006.